On October 10, 2024, the U.S. Environmental Protection Agency (EPA) released interim guidance aimed at expanding the labeling of antimicrobial products, allowing sanitizers to include claims of effectiveness against viruses. This guidance applies to products like household wipes and sprays registered with sanitizing claims. If laboratory data demonstrates their efficacy in meeting EPA’s established criteria for virucidal claims, these sanitizers can now add virus-killing claims to their labels.

On October 2, 2024, the U.S. Department of Agriculture (USDA), Environmental Protection Agency (EPA), and Food and Drug Administration (FDA) jointly launched a web-based tool designed to guide companies in developing microbial biotechnology products. The newly released tool, hosted on the Unified Website for Biotechnology Regulation, aims to help developers, especially those new to the industry, navigate the complex regulatory landscape.

On October 1, 2024, the U.S. Environmental Protection Agency (EPA) introduced new measures to safeguard federally endangered species and their critical habitats from the effects of chlorpyrifos. These measures, including revised product labels and region-specific Endangered Species Protection Bulletins, are designed to reduce exposure risks for both listed and non-listed species.

EU Pesticide Regulation (EC) No 1107/2009（referred to as EU PPPs Regulation）lays down harmonized rules for the approval of active substances and the placing on the market of plant protection products in the European Union. It was published in 2009 to replace old Directive 91/414/EEC and was entered into effect on 14th, June 2011.

On August 6 and 7, the U.S. Environmental Protection Agency (EPA) issued significant orders to address health risks posed by two widely used pesticides: Dacthal (DCPA or dimethyl tetrachloroterephthalate) and chlorpyrifos.

On June 5, 2024, the Biocidal Products Committee (BPC) of the European Chemicals Agency (ECHA) adopted four opinions on active substances and seven on Union authorisations during its May meeting, noting a rise in opinions not supporting approvals due to insufficient data.